Clinical trial
QRS Microfragmentation in ECG as Predictor of Mortality and Morbidity - a Retrospective Analysis
NCT06011590 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- QRS Microfragmentation in ECG as Predictor of Mortality and Morbidity - a Retrospective Analysis
- Lead sponsor
- Medical University Innsbruck
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2000
- Completion date
- July 31, 2022
- Enrollment
- 150,000 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
risk stratification